Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | See Remarks | May 19, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,409 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 15,409 · Balance 15,409 F1: Consists of 15,409 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.13 · Expires 2036-03-09 | Direct | 23,171 |
Reported balance
After 2026-05-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-19 · Grant · Acquired 23,171 · Balance 23,171 F2: The option vests as to 25% of the shares underlying the option on March 9, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 15,409 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: The option vests as to 25% of the shares underlying the option on March 9, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2026 Filed May 21, 2026 22:47 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 23,171 | $0.00 Strike: $66.13 | $0.00 |
DisclosureSEC source: 0001193125-26-235072 · ownership.xml · derivative · entry 2 Forsyth Matthew S. · CIK 0002120002 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,171 Underlying: Common Stock · 23,171 shares Expires 2036-03-09 F2 · derivative.exercise_date: The option vests as to 25% of the shares underlying the option on March 9, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. Read SEC document |
| May 19, 2026 Filed May 21, 2026 22:47 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 15,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-235072 · ownership.xml · nonDerivative · entry 1 Forsyth Matthew S. · CIK 0002120002 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,409 F1 · shares: Consists of 15,409 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.